Overview

Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine

Status:
Unknown status
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Antipsychotic drugs can cause a clinically relevant hyperprolactinemia due to blocking the dopamine receptors in the pituitary.Schizophrenic patients suffering from a neuroleptic-induced hyperprolactinemia will be examined endocrinologically. Adverse drug effects and diagnoses will be confirmed by measuring hormones.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Bonn
Treatments:
Bromocriptine
Risperidone